Oramed COO, CBO Joshua Hexter disposes of $135,330 in common shares

ORMP•2026-10-02

Oramed COO and CBO Joshua Hexter sold 30,000 common shares on Oct. 1, 2026, at a weighted-average price of $4.511 per share, leaving him with 1,328,130 shares.

1. Share sale

Joshua Hexter sold 30,000 Oramed Pharmaceuticals common shares on Oct. 1, 2026, at a weighted-average price of $4.511 per share. His post-transaction holding totaled 1,328,130 shares.

Sources

Oramed COO, CBO Joshua Hexter disposes of $135,330 in common shares

Sec

Oramed COO, CBO Joshua Hexter disposes of $135,330 in common shares

1. Share sale

Related News

AnaptysBio director Renton Hollings disposes of $249,371 in common shares

Newell Brands entered into second amendment to receivables purchase agreement dated Oct. 2, 2023

Beyond Air files initial beneficial ownership statement for Yi-Chien Lin

Sources

Oramed COO, CBO Joshua Hexter disposes of $135,330 in common shares

Dragonfly Energy amends senior secured term loan, adds $450,000 paid-in-kind fee

Almonty says Pure Tungsten issues corrective disclosure on Tiger Kim's role at Sangdong mine